Why is Welcure Drugs falling/rising?

As of 31-Oct, Welcure Drugs & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 0.55, which reflects a decrease of 0.02 or 3.51%. The stock has been underperforming significantly, having lost 28.57% over the last eight days, and it is trading below all key moving averages (5-day, 20-day, 50-day, 100-day, and 200-day). Additionally, the stock's performance over the past week shows a substantial drop of 19.12%, while it has only gained 5.91% over the past month. There is no information available regarding positive or negative factors that could influence the stock's recent movement. Broader Market Context: In comparison to the benchmark Sensex, which has seen a slight decline of 0.32% over the past week, Welcure Drugs' performance is markedly worse. The stock's liquidity appears to be adequate for trading, but the delivery volume has decreased by 13.54% against the 5-day average, indicating falling investor participation. Year-to-date, Welcure Drugs has underperformed significantly with a decline of 47.63%, contrasting sharply with the Sensex's gain of 7.42%.